The US Endoprosthesis Market is experiencing significant growth, projected to expand from USD 11.38 billion in 2024 to USD 32.89 billion by 2034, with a CAGR of 11.20% during the forecast period. This growth is driven by factors such as the increasing prevalence of age-related osteoarthritis, advancements in implant technologies, and a growing geriatric population seeking joint replacement solutions. The knee segment currently dominates the market, with revision knee replacements contributing the most to revenue. Technological innovations, including the integration of smart sensors and robotics in surgical procedures, are enhancing the precision and outcomes of joint replacement surgeries. Additionally, the rise in healthcare awareness and improved access to medical facilities are further propelling market expansion.

As the market evolves, there is a notable shift towards personalized medicine and minimally invasive surgical techniques. These trends are prompting manufacturers to develop customized implants and advanced surgical tools that cater to individual patient needs. Furthermore, strategic collaborations and mergers among key players are expected to foster innovation and expand product portfolios, thereby intensifying competition and accelerating market growth in the US Endoprosthesis Market.